| Financial Year |
March 31 2023 |
| Monetary Funds |
1,270,954,320.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
337,667,325.69 |
| Advances to Suppliers |
116,108,228.12 |
| Other Receivables |
320,293,719.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,061,929,777.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,610,008.86 |
| Total Current Assets |
3,622,035,181.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
912,248,633.06 |
| Under-construction Projects |
24,103,752.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
139,866,787.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,093,919.97 |
| Deferred Income Tax Assets |
104,807,863.43 |
| Other Non-Current Assets |
56,893,438.03 |
| Sub-Total of Non-Current Assets |
1,247,824,117.00 |
| Total Assets |
4,869,859,298.46 |
| Short-Term Loans |
200,477,352.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
126,939,577.83 |
| Accounts Payable |
629,637,400.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,411,381.16 |
| Taxes Payable |
36,986,882.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
177,844,548.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
153,978,324.77 |
| Other Current Liabilities |
47,139,385.61 |
| Sub-Total of Current Liabilities |
1,753,471,690.33 |
| Long-term Loans |
393,400,445.10 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,614,183.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
535,999,247.74 |
| Total Liabilities |
2,289,470,938.07 |
| Paid-In Capital(Or Share Stock) |
518,650,649.00 |
| Capital Surplus |
1,418,141,120.25 |
| Surplus Reserve |
76,049,118.78 |
| LESS:Treasury Stock |
107,498,437.20 |
| Undistributed Profits |
390,484,571.98 |
| Minority Stockholder's Interest |
211,500,413.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,368,887,946.50 |
| Owner's Equity（Stockholder's Equity） |
2,580,388,360.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,869,859,298.46 |
